|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| A61P 19/00 | |||
| C07K 16/24 |
| (11) | Patento numeris | 1715891 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05702390.5 |
| Europos patento paraiškos padavimo data | 2005-01-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2006-11-02 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2010-04-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2005/000240 |
| Data | 2005-01-31 |
| (87) | Numeris | WO 2005/080429 |
| Data | 2005-09-01 |
| (30) | Numeris | Data | Šalis |
| 543814 P | 2004-02-11 | US |
| (72) |
BOVE, Susan, Elizabeth Pfizer Global Research &, US
KILGORE, Kenneth, Stanley Pfizer Global Research, US
|
| (73) |
Warner-Lambert Company LLC,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | METHODS OF TREATING OSTEOARTHRITIS WITH ANTI-IL-6 ANTIBODIES |
| METHODS OF TREATING OSTEOARTHRITIS WITH ANTI-IL-6 ANTIBODIES |